Asmahane Benmaziane

Hôpital Foch — France

Medicine · Health Sciences

6h-index71citations23works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Venous Thromboembolism Diagnosis and Management(9), HER2/EGFR in Cancer Research(5), Acute Ischemic Stroke Management(4), Cancer Treatment and Pharmacology(4), Atrial Fibrillation Management and Outcomes(3)

Publications23 total

984P FIPO23: A first-in-human trial of XON7, a Glyco-Humanized Polyclonal Antibody (GHpAb)targeting multiple tumor antigens in advanced solid tumors
Annals of Oncology·2025
The management of cancer-associated thromboembolism: Proposals from the French multidisciplinary INNOVTE CAT Working Group
Archives of cardiovascular diseases·2025Open Access
387eTiP DOVIPA: A phase II study with safety run-in of mFOLFIRINOX, dostarlimab, and oral vitamin D in metastatic pancreatic cancer with translational research on resistance mechanisms
Annals of Oncology·2025Open Access
Abstract P5-10-15: Effectiveness and tolerance of Trastuzumab Deruxtecan (T-DXd) in HER2-Positive and HER2-Low Metastatic Breast Cancer (MBC): a large real-life French Cohort Study
Clinical Cancer Research·2025
Safety and efficacy of combined trastuzumab-deruxtecan and concurrent radiation therapy in breast cancer. The TENDANCE multicentric French study
The Breast·2025· 8 citedOpen Access
Pneumopathies interstitielles diffuses liées au Trastuzumab Deruxtecan : résultats d’une large cohorte française en vie réelle chez des patients atteints de cancer du sein HER2-dépendant et autres tumeurs
Revue des Maladies Respiratoires Actualités·2025· 1 cited
Trastuzumab Deruxtecan (T-DXd)-associated interstitial lung disease (ILD) in a large real-world French cohort of patients with HER2-driven breast cancer and other malignancies.
2024· 2 cited
346MO Trastuzumab deruxctecan (T-DXd) associated interstitial lung disease (ILD) in a large real-world French cohort of patients with HER2-driven breast cancer and other malignancies
Annals of Oncology·2024· 5 citedOpen Access
Traduction et republication de : « Événements thromboemboliques artériels liés au cancer »
La Revue de Médecine Interne·2024
An Ovarian Intracranial Collision Tumor: A Case Report and Review of the Literature
Indian Journal of Gynecologic Oncology·2024
Traduction et republication de : « Traitement de la maladie thromboembolique veineuse associée au cancer chez les patients en soins palliatifs »
La Revue de Médecine Interne·2024
REPROGRAM-02: A phase II-III study evaluating an induction treatment with regorafenib and metronomic chemotherapy before the second line chemotherapy in metastatic colorectal cancer.
Journal of Clinical Oncology·2024
Traduction et republication de : « Thrombose veineuse profonde du membre supérieur associée à un cathéter veineux central chez les patients cancéreux : diagnostic et prise en charge thérapeutique »
La Revue de Médecine Interne·2024
Traduction et republication de : « Prise en charge de la maladie thromboembolique veineuse associée au cancer chez les populations vulnérables »
La Revue de Médecine Interne·2024
Traduction et republication de : « Maladie thromboembolique veineuse récidivante chez les patients cancéreux anticoagulés : diagnostic et traitement »
La Revue de Médecine Interne·2024
Traduction et republication de : « Traitement à domicile des patients atteints de maladie veineuse thromboembolique associée au cancer »
La Revue de Médecine Interne·2024
Pembrolizumab and Campylobacter Jejuni Induced Guillain-Barré Syndrome in a Patient with Advanced Duodenal Adenocarcinoma: A Case Report and Literature Review
Journal of Oncology Research Review & Reports·2024Open Access
Anticoagulant treatment of cancer-associated thromboembolism
Archives of cardiovascular diseases·2023· 22 cited
Home treatment for patients with cancer-associated venous thromboembolism
Archives of cardiovascular diseases·2023· 7 cited
Pembrolizumab and Campylobacter Jejuni induced Guillain- Barré syndrome in a patient with advanced duodenal adenocarcinoma: a case report and literature review.
2023· 1 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Isabelle Mahé(14), Olivier Sanchez(14), Françis Couturaud(10), Laurent Bertoletti(10), Antoine Élias(10), Olivier Espitia(10), Philippe Girard(9), Jeannot Schmidt(9), Farès Moustafa(9), Y. Benhamou(8), Patrick Mismetti(8), Yoann Gaboreau(8), Marie‐Antoinette Sevestre(8), Silvy Laporte(7), Pierre‐Marie Roy(7), P. Debourdeau(7), Olivier Hanon(7), D. Mayeur(6), V. Bichon(6), C. Bozec(6)